Improving patient care and safety is Flo Healthcare’s top priority as the company works with clinical software and OEM business partners to deliver patented, integrated solutions—infrastructure, devices and services—to medical facilities. With 45,000 mobile devices and wireless infrastructure systems installed within approximately 800 hospitals, Flo Healthcare is the acknowledged leader in total hospital and system-wide wireless and mobile clinical workstation installations across the United States and Canada.

Electronic submission of diagnostic medical imaging can be utilized in clinical drug trials to speed the submission and independent analysis of medical imaging diagnostics by central imaging labs while also increasing quality of data.

Many experimental approaches in biology and biophysics, as well as applications in diagnosis and drug discovery, require proteins to be immobilized on solid supports. Protein microarrays, for example, provide a high-throughput format to study biomolecular interactions. The technique employed for protein immobilization is a key to the success of these applications. Recent biochemical developments are allowing, for the first time, the selective and traceless immobilization of proteins generated by cell-free systems without the need for purification and/or reconcentration prior to the immobilization step.Many experimental approaches in biology and biophysics, as well as applications in diagnosis and drug discovery, require proteins to be immobilized on solid supports. Protein microarrays, for example, provide a high-throughput format to study biomolecular interactions. The technique employed for protein immobilization is a key to the success of these applications. Recent biochemical developments are allowing, for the first time, the selective and traceless immobilization of proteins generated by cell-free systems without the need for purification and/or reconcentration prior to the immobilization step.

Advances in technology will enhance innovation and growth in the life sciences. As increasingly complex information is generated, the need to develop smart technology becomes even more important. Bioinformatics will have to continuously discover new ways to collect, organize, interpret, share, analyze, and reconcile often incompatible information formats. There is no doubt that innovation and technological change are inextricably linked. The challenge is keeping up with these changes and managing the human impact. All too often the focus is on implementing the new technology without taking into consideration how the people who must adapt to the changes will be affected. It is essential to understand that technical systems do not stand alone but rather they are interdependent with social systems.

It’s clear that to survive the changes in the current economic environment, including the globalization of products and services, life science companies must run lean and efficient organizations.

It’s clear that to survive the changes in the current economic environment, including the globalization of products and services, life science companies must run lean and efficient organizations.

Available methods for producing and screening high-affinity ligands against particular molecular targets are either based in rational or combinatorial approaches. The rational approach usually requires the molecular structure of the bimolecular target, and then potential binders are selected from a virtual library of compounds using docking software. Despite recent advances in computing technology and the development of adaptive docking software, this is still a slow, although promising, process.